Depression Cognitive Research is a medical app providing digital cognitive assessment and stimulation tools for neuroscience researchers and clinical study participants.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
—
—
Nemesis
Migraine Buddy: Track Headache
The App DNA
What makes this app unique?
Researchers hire this tool to standardize cognitive data collection across diverse populations, while individuals use it to monitor cognitive health markers associated with mood disorders.
For Healthcare professionals, researchers, and individuals seeking to monitor or improve cognitive health through scientifically-validated digital tools.
What does it look like?
Key features
Standardized digital tests measuring 20+ cognitive domains including attention, memory, and processing speed
AI-driven training schedules that adapt difficulty levels based on user performance in cognitive tasks
Detailed analytics tracking cognitive development and identifying potential function deficits over time
How much does it cost?
Freemium model uses a 10-license free trial to seed B2B and family adoption, converting users into recurring subscription revenue.
Velocity
Maintenance developmentShow more...
5 versions in history. Development pace: maintenance.
Who built it?
CogniFit
13+ apps tracked · Medical
CogniFit - Brain Training
CogniFit - Brain Training
ADHD - Cognitive Research
Dyslexia - Cognitive Research
Fibromyalgia - Research
Dyscalculia Cognitive Research
Parkinson's Cognitive Research
MindFit: Meditation & Sleep
Brain Health PRO
Insomnia - Cognitive Research
Chemo Brain Cognitive Research
BabybrightUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Depression Cognitive Research
How's the Medical market?
The app maintains a research-focused position in the Medical category, though the lack of rating volume across both platforms suggests it has yet to achieve consumer-facing market penetration.
Read the market outlookThe rivals identified
By Voluntis
This is the most mature symptom-tracking competitor in the medical category with a massive, highly-engaged user base.
- Provides comprehensive longitudinal symptom mapping that allows users to identify specific environmental and behavioral triggers.
- Integrates advanced data export features that enable patients to share detailed health reports directly with physicians.
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Depression Cognitive Research
Where is it heading?
The medical-tracking market is shifting toward high-engagement, gamified experiences that prioritize daily habit formation. Without a pivot to consumer-facing features, this app will remain a niche research tool, missing the opportunity to capture the broader cognitive health market.
- Recent updates focused on stability and security, suggesting the app remains in a maintenance phase rather than active feature expansion.
- The absence of user ratings across platforms suggests a lack of organic discovery, which limits the potential for future revenue growth.
The SWOT
- Scientific validation across 20+ cognitive domains provides a professional-grade barrier to entry
- AI-driven training plans reduce churn by tailoring difficulty to user skill
- Untapped education partnerships for B2B distribution
- Integration of wearable data to bridge hardware with cognitive insights
Next best moves
Pivot trial model to a freemium consumer tier because the 10-license limit restricts individual adoption → increase user base
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of consumer ratings is not…
Read the full takeFeature gaps
Gamified daily logging (available in mySugr but absent here) +2
Since the last report: The report identifies a transition from a passive research-only tool to a product struggling with a B2B-centric pricing model that limits consumer growth.
Bottom line
The app provides a rigorous tool for neuroscience research, but its B2B-only trial structure prevents consumer growth, so the PM should pivot to a consumer-facing freemium model to capture individual users.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated